< Back to previous page
Researcher
Evelien Peeters
- Keywords:Cancer Therapy, Breast cancer
- Disciplines:Cancer therapy, Biopharmaceuticals, In vitro testing, Non-clinical studies
Affiliations
- Department of Biomedical molecular biology (Department)
Member
From1 Sep 2021 → 31 Oct 2021 - Department of Diagnostic Sciences (Department)
Member
From1 Sep 2020 → Today
Projects
1 - 1 of 1
- An alternative more tolerable L-asparaginase variant for the treatment of metastatic breast cancerFrom1 Nov 2021 → TodayFunding: FWO Strategic Basic Research Grant
Publications
1 - 3 of 3
- In vivo stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemia(2023)
Authors: Maaike Van Trimpont, Amanda M. Schalk, Yanti De Visser, Hien Anh Nguyen, Lindy Reunes, Katrien Vandemeulebroecke, Evelien Peeters, Ying Su, Hyun Lee, Philip L. Lorenzi, et al.
Pages: 409 - 419 - In vivo stabilization of a less toxic asparaginase variant leads to a durable anti-tumor response in acute leukemia(2023)
Authors: Amanda M. Schalk, Yanti De Visser, Hien Anh Nguyen, Lindy Reunes, Evelien Peeters, Ying Su, Hyun Lee, Philip L. Lorenzi, Wai-Kin Chan, Veerle Mondelaers, et al.
Pages: 409 - 419 - Novel insights on the use of L-asparaginase as an efficient and safe anti-cancer therapy(2022)
Authors: Maaike Van Trimpont, Evelien Peeters, Yanti De Visser, Amanda M. Schalk, Veerle Mondelaers, Barbara De Moerloose, Arnon Lavie, Tim Lammens, Steven Goossens, Pieter Van Vlierberghe